Skip to main content

Table 3 Adverse events of the patients after treatment

From: Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study

Adverse events Any Grade 1 Grade 2  ≥ Grade 3
  No (%) No (%) No (%) No (%)
Appetite loss 24 57.1 19 45.2 5 11.9 0 0
Nausea 23 54.8 19 45.2 4 9.5 0 0
Vomiting 12 28.6 7 16.7 5 11.9 0 0
Diarrhea 4 9.5 3 7.1 0 0 1 2.4
Neutropenia 24 57.1 16 38.1 7 16.7 1 2.4
Thrombocytopenia 25 59.5 12 28.6 13 31.0 0 0
Increased ALT 9 21.4 9 21.4 0 0 0 0
Increased AST 12 28.6 12 28.6 0 0 0 0
Hyperbilirubinemia 16 38.1 16 38.1 0 0 0 0
Rash 1 2.4 0 0 1 2.4 0 0
Fatigue 13 31.0 9 21.4 4 9.5 0 0
Weight loss 8 19.0 5 11.9 3 7.1 0 0
Peripheral neuropathy 8 19.0 7 16.7 1 2.4 0 0